Stockreport

Veracyte: Profitable, De-Risked, And Ready To Run [Seeking Alpha]

Veracyte, Inc.  (VCYT) 
Last veracyte, inc. earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF Key 2025-2026 catalysts include deeper prostate cancer penetration, entry into minimal residual disease, and U.S. re-launch of the Prosigna breast cancer test. VCYT p [Read more]